Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's síndrome
4EBPs
eIF4E-binding proteins
AMPA
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
BDNF
brain-derived neurotrophic factor
CHX
cycloheximide
DG
dentate gyrus
DS
Down's syndrome
eIF4E
eukaryotic translation initiation factor 4E
ERK
extracellular signal-regulated kinase
FDA
Food and Drug Administration
fEPSPs
field excitatory postsynaptic potentials
GABA
gamma-aminobutyric acid
HFS
high frequency stimulation
LTD
long-term depression
LTM
long-term memory
LTP
Long-term potentiation
MEK
MAPK/ERK kinase
Mnk1
mitogen-activated protein kinase integrating kinase 1
mTOR
mammalian target of rapamycin
NMDAR
N-methyl D-aspartate receptor
p70S6K
p70 S6 kinase
PDK1
phosphoinositide-dependent kinase 1
PI3K
phosphatidylinositol 3-kinase
PIP2
phosphatidilynositol 4,5-bisphosphate
PIP3
phosphatidylinositol 3,4,5-trisphosphate
PPF
paired-pulse facilitation
PPR
paired-pulse ratio
PTEN
Phosphatase and tensin homolog on chromosome ten
RSK
p90 ribosomal S6 kinase
TrkB
tropomyosin-related kinase B
TSC
tuberous sclerosis complex
WT
wild-type
Keywords
Barnes maze
BDNF-LTP
ERK
MTOR
Pharmacotherapy
Rapamycin
Synaptic plasticity
Trisomy 21
Ts1Cje
No hay comentarios:
Publicar un comentario
Aportes